000857537 001__ 857537
000857537 005__ 20240625095127.0
000857537 0247_ $$2doi$$a10.1124/mol.118.112375
000857537 0247_ $$2ISSN$$a0026-895X
000857537 0247_ $$2ISSN$$a0026-895x
000857537 0247_ $$2ISSN$$a1521-0111
000857537 0247_ $$2pmid$$apmid:30012583
000857537 0247_ $$2WOS$$aWOS:000445669700003
000857537 037__ $$aFZJ-2018-06528
000857537 082__ $$a610
000857537 1001_ $$0P:(DE-HGF)0$$aReiners, Melissa$$b0
000857537 245__ $$aThe Conorfamide RPRFa Stabilizes the Open Conformation of Acid-Sensing Ion Channel 3 via the Nonproton Ligand–Sensing Domain
000857537 260__ $$aBethesda, Md.$$bASPET$$c2018
000857537 3367_ $$2DRIVER$$aarticle
000857537 3367_ $$2DataCite$$aOutput Types/Journal article
000857537 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1547623011_15236
000857537 3367_ $$2BibTeX$$aARTICLE
000857537 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000857537 3367_ $$00$$2EndNote$$aJournal Article
000857537 520__ $$aAcid-sensing ion channel 3 (ASIC3) is a proton-gated Na+ channel with important roles in pain. ASIC3 quickly desensitizes in less than a second, limiting its capacity to sense sustained acidosis during pain. RFamide neuropeptides are modulators of ASIC3 that slow its desensitization and induce a variable sustained current. The molecular mechanism of slowed desensitization and the RFamide binding site on ASIC3 are unknown. RPRFamide, a RFamide from the venom of a cone snail, has a comparatively high affinity for ASIC3 and strongly slows its desensitization. Here we show that covalent binding of a UV-sensitive RPRFamide variant to ASIC3 prevents desensitization, suggesting that RPRFamide has to unbind from ASIC3 before it can desensitize. Moreover, we show by in silico docking to a homology model of ASIC3 that a cavity in the lower palm domain, which is also known as the nonproton ligand–sensing domain, is a potential binding site of RPRFamide. Finally, using extensive mutagenesis of residues lining the nonproton ligand–sensing domain, we confirm that this domain is essential for RPRFamide modulation of ASIC3. As comparative analysis of ASIC crystal structures in the open and in the desensitized conformation suggests that the lower palm domain contracts during desensitization, our results collectively suggest that RPRFamide, and probably also other RFamide neuropeptides, bind to the nonproton ligand–sensing domain to stabilize the open conformation of ASIC3.
000857537 536__ $$0G:(DE-HGF)POF3-574$$a574 - Theory, modelling and simulation (POF3-574)$$cPOF3-574$$fPOF III$$x0
000857537 536__ $$0G:(DE-HGF)POF3-511$$a511 - Computational Science and Mathematical Methods (POF3-511)$$cPOF3-511$$fPOF III$$x1
000857537 588__ $$aDataset connected to CrossRef
000857537 7001_ $$0P:(DE-HGF)0$$aMargreiter, Michael A.$$b1
000857537 7001_ $$0P:(DE-HGF)0$$aOslender-Bujotzek, Adrienne$$b2
000857537 7001_ $$0P:(DE-Juel1)145921$$aRossetti, Giulia$$b3$$ufzj
000857537 7001_ $$0P:(DE-HGF)0$$aGründer, Stefan$$b4$$eCorresponding author
000857537 7001_ $$0P:(DE-HGF)0$$aSchmidt, Axel$$b5$$eCorresponding author
000857537 773__ $$0PERI:(DE-600)1475030-2$$a10.1124/mol.118.112375$$gVol. 94, no. 4, p. 1114 - 1124$$n4$$p1114 - 1124$$tMolecular pharmacology$$v94$$x1521-0111$$y2018
000857537 8564_ $$uhttps://juser.fz-juelich.de/record/857537/files/mol.118.112375.full-1.pdf$$yRestricted
000857537 8564_ $$uhttps://juser.fz-juelich.de/record/857537/files/mol.118.112375.full-1.pdf?subformat=pdfa$$xpdfa$$yRestricted
000857537 909CO $$ooai:juser.fz-juelich.de:857537$$pVDB
000857537 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145921$$aForschungszentrum Jülich$$b3$$kFZJ
000857537 9131_ $$0G:(DE-HGF)POF3-574$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vTheory, modelling and simulation$$x0
000857537 9131_ $$0G:(DE-HGF)POF3-511$$1G:(DE-HGF)POF3-510$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lSupercomputing & Big Data$$vComputational Science and Mathematical Methods$$x1
000857537 9141_ $$y2018
000857537 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL PHARMACOL : 2017
000857537 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000857537 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000857537 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000857537 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000857537 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000857537 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000857537 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000857537 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000857537 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000857537 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000857537 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000857537 920__ $$lyes
000857537 9201_ $$0I:(DE-Juel1)IAS-5-20120330$$kIAS-5$$lComputational Biomedicine$$x0
000857537 9201_ $$0I:(DE-Juel1)INM-9-20140121$$kINM-9$$lComputational Biomedicine$$x1
000857537 9201_ $$0I:(DE-Juel1)JSC-20090406$$kJSC$$lJülich Supercomputing Center$$x2
000857537 980__ $$ajournal
000857537 980__ $$aVDB
000857537 980__ $$aI:(DE-Juel1)IAS-5-20120330
000857537 980__ $$aI:(DE-Juel1)INM-9-20140121
000857537 980__ $$aI:(DE-Juel1)JSC-20090406
000857537 980__ $$aUNRESTRICTED